Amneal Pharmaceuticals, Inc. (AMRX)
$0.00+$0.00 (+0.00%) TodayExtended Hours
Andrew S. Boyer - OfficerAmneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 413,016 | $7.22M |
| Grant or award | 4 | 25,810,569 | |
| Option exercise | 1 | 168,573 | |
| Bona-fide gift | 2 | 162,426 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
48 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jason B. Daly - Officer | Grant or award | Restricted Stock Units | 65,359 | $0.00 | - | |
| Jason B. Daly - Officer | Grant or award | Performance-Based Restricted Stock Units | 65,359 | $0.00 | - | |
| Andrew S. Boyer - Officer | Grant or award | Restricted Stock Units | 65,359 | $0.00 | - | |
| Andrew S. Boyer - Officer | Grant or award | Performance-Based Restricted Stock Units | 65,359 | $0.00 | - | |
| Ted C. Nark - Director | Open-market sale | Class A Common Stock | 50,000 | $11.72 | $586K | |
| Nikita Shah - Officer | Option exercise | Stock Option (Right to Buy) | 95,525 | $0.00 | - | |
| Nikita Shah - Officer | Option exercise | Class A Common Stock | 36,331 | $2.75 | $100K | |
| Nikita Shah - Officer | Option exercise | Class A Common Stock | 95,525 | $2.75 | $263K | |
| Nikita Shah - Officer | Open-market sale | Class A Common Stock | 131,856 | $11.92 | $1.57M | |
| Nikita Shah - Officer | Option exercise | Stock Option (Right to Buy) | 36,331 | $0.00 | - | |
| John Kiely - Director | Open-market sale | Class A Common Stock | 32,000 | $9.23 | $295K | |
| Nikita Shah - Officer | Open-market sale | Class A Common Stock | 114,492 | $9.66 | $1.11M | |
| Nikita Shah - Officer | Open-market sale | Class A Common Stock | 6,340 | $9.50 | $60K | |
| Andrew S. Boyer - Officer | Option exercise | Class A Common Stock | 175,000 | $2.75 | $481K | |
| Andrew S. Boyer - Officer | Open-market sale | Class A Common Stock | 279,244 | $9.38 | $2.62M | |
| Andrew S. Boyer - Officer | Option exercise | Stock Option | 175,000 | $0.00 | - | |
| Nikita Shah - Officer | Open-market sale | Class A Common Stock | 71,694 | $9.29 | $666K | |
 Tasos Konidaris - Officer | Open-market sale | Class A Common Stock | 161,365 | $9.22 | $1.49M | |
| Tasos Konidaris - Officer | Open-market sale | Class A Common Stock | 119,206 | $9.30 | $1.11M | |
| Tasos Konidaris - Officer | Open-market sale | Class A Common Stock | 219,159 | $9.43 | $2.07M | |
| Andrew S. Boyer - Officer | Open-market sale | Class A Common Stock | 33,436 | $9.05 | $303K | |
| Nikita Shah - Officer | Open-market sale | Class A Common Stock | 50,000 | $9.04 | $452K | |
| Jason B. Daly - Officer | Open-market sale | Class A Common Stock | 22,000 | $9.05 | $199K | |
| Paul M. Meister - Director | Option exercise | Class A Common Stock | 56,361 | - | - | |
| Paul M. Meister - Director | Option exercise | Restricted Stock Units | 56,361 | $0.00 | - | |
| Paul M. Meister - Director | Grant or award | Restricted Stock Units | 48,747 | $0.00 | - | |
| J. Kevin Buchi - Director | Option exercise | Class A Common Stock | 40,258 | - | - | |
| J. Kevin Buchi - Director | Option exercise | Restricted Stock Units | 40,258 | $0.00 | - | |
| J. Kevin Buchi - Director | Grant or award | Restricted Stock Units | 34,819 | $0.00 | - | |
| John Kiely - Director | Option exercise | Class A Common Stock | 28,506 | $4.76 | $136K | |
| John Kiely - Director | Open-market sale | Class A Common Stock | 17,058 | $8.38 | $143K | |
| John Kiely - Director | Option exercise | Stock Option | 28,506 | $0.00 | - | |
| Deborah M. Autor - Director | Open-market sale | Class A Common Stock | 6,771 | $8.41 | $57K | |
| Deborah M. Autor - Director | Open-market sale | Class A Common Stock | 33,229 | $8.34 | $277K | |
| Jason B. Daly - Officer | Open-market sale | Class A Common Stock | 13,665 | $8.40 | $115K | |
| Jason B. Daly - Officer | Open-market sale | Class A Common Stock | 43,657 | $8.61 | $376K |
This is as far as the anonymous view goes. Create a free account for all 48 AMRX filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JOHN KIELY | Director | 50,000 | $880K | View on EDGAR | |
| NIKITA SHAH | Officer | 146,403 | $2.56M | View on EDGAR | |
| JASON DALY | OFFICER | 210,000 | $3.65M | View on EDGAR |
Amneal Pharmaceuticals, Inc. (AMRX) had 9 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for AMRX runs to 48 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of AMRX were filed in the last 90 days.
4 insider sales of AMRX were filed in the last 90 days, totaling $7.22M.
This page tracks AMRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AMRX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
